Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
Asset disposition
Acq. announced
NEKTAR THERAPEUTICS (NKTR) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/10/2023 SC 13G/A Invesco Ltd. reports a 2.9% stake in Nektar Therapeutics
07/10/2023 SC 13G/A VANGUARD GROUP INC reports a 6.4% stake in Nektar Therapeutics
07/07/2023 SC 13G/A BlackRock Inc. reports a 4.5% stake in NEKTAR THERAPEUTICS
07/07/2023 SC 13G/A PRIMECAP MANAGEMENT CO reports a 4.3% stake in Nektar Therapeutics
05/05/2023 SC 13G/A BlackRock Inc. reports a 9.7% stake in NEKTAR THERAPEUTICS
02/09/2023 SC 13G/A PRIMECAP MANAGEMENT CO reports a 8.3% stake in Nektar Therapeutics
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 12.3% stake in Nektar Therapeutics Class A
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2023 SC 13G/A Invesco Ltd. reports a 19.9% stake in Nektar Therapeutics
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2022 SC 13G/A PRIMECAP MANAGEMENT CO reports a 9.4% stake in Nektar Therapeutics
02/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/27/2022 SC 13G/A BlackRock Inc. reports a 14.5% stake in NEKTAR THERAPEUTICS
01/25/2022 SC 13G/A BlackRock Inc. reports a 14.5% stake in NEKTAR THERAPEUTICS
01/10/2022 SC 13G/A VANGUARD GROUP INC reports a 10% stake in Nektar Therapeutics Class A
12/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/10/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/07/2020 SC 13G/A Invesco Ltd. reports a 18% stake in Nektar Therapeutics
02/07/2020 SC 13G/A FMR LLC reports a 8.5% stake in NEKTAR THERAPEUTICS
02/04/2020 SC 13G/A BlackRock Inc. reports a 10.5% stake in NEKTAR THERAPEUTICS
01/27/2020 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 9.2% stake in NEKTAR THERAPEUTICS
11/08/2019 SC 13G/A BlackRock Inc. reports a 10.7% stake in NEKTAR THERAPEUTICS
10/10/2019 SC 13G/A Invesco Ltd. reports a 19.8% stake in Nektar Therapeutics
08/12/2019 SC 13G/A FMR LLC reports a 9.8% stake in NEKTAR THERAPEUTICS ?
02/13/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy